Cite

    Barco, S. et al. (2020). Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. European heart journal. pp. 509-518. [Online].